Cite
HARVARD Citation
Chang, S. et al. (2015). Simvastatin–ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study. International journal of cardiology. pp. 20-25. [Online].